Empowering People Hurt by Big Businesses

Local (415) 319-8833
Toll Free (855) 534-0061

Blog Posts in May, 2012

  • DEFECTIVE DESIGN THEORY IN CALIFORNIA PRODUCT LIABILITY LAW

    In our last post, we discussed a wrongful death and product liability lawsuit brought by the family of a California oil refinery worker who died of mesothelioma. The family brought the lawsuit against the manufacturer of asbestos insulation that the worker was exposed to at an El Segundo refinery. The family sought to hold the manufacturer liable under a "design defect" theory of product liability ...
    Continue Reading
  • REFINERY WORKER'S FAMILY BRINGS MESOTHELIOMA LAWSUIT AGAINST MANUFACTURER

    The family of a former California oil refinery worker recently brought a wrongful death and product liability lawsuit against the manufacturer of asbestos insulation. Many individuals throughout California have been exposed to asbestos-containing materials in the workplace. Asbestos is a naturally occurring mineral that was used in thousands of products to make materials stronger and ...
    Continue Reading
  • ABBOTT LABORATORIES TO PAY $1.5 BILLION FOR MISMARKETING DEPAKOTE

    It is not uncommon for large drugmakers to market drugs for uses that have not been approved by the U.S. Food and Drug Administration. This practice, known as "off-label marketing," can result in billions of dollars in profits for drugmakers, but can also cause significant patient harm. Abbott Laboratories recently agreed to pay federal authorities $1.5 billion because of its off-label promotion ...
    Continue Reading
  • TAKEDA FAILS TO GET FDA APPROVAL FOR ACTOS FOLLOW-UP

    The giant drugmaker Takeda Pharmaceutical Co. has failed to secure federal approval to market its follow-up to the diabetes drug Actos. Takeda sought to sell its diabetes drug, called alogliptin, in the U.S., but the Food and Drug Administration has requested more information on the cardiovascular risks associated with this potentially dangerous pharmaceutical. Federal regulators may be more ...
    Continue Reading
Page 1 of 1